XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 25, 2023   124,794      
Balance at beginning of period at Jun. 25, 2023 $ 1,621.9 $ 0.2 $ 3,711.0 $ (2,064.2) $ (25.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (395.7)     (395.7)  
Unrealized gain (loss) on available-for-sale securities 1.9       1.9
Tax withholding on vested equity awards (15.0)   (15.0)    
Stock-based compensation (in shares)   506      
Stock-based compensation 32.1   32.1    
Exercise of stock options and issuance of shares (in shares)   21      
Exercise of stock options and issuance of shares 0.5   0.5    
Balance at end of period (in shares) at Sep. 24, 2023   125,321      
Balance at end of period at Sep. 24, 2023 1,245.7 $ 0.2 3,728.6 (2,459.9) (23.2)
Balance at beginning of period (in shares) at Jun. 25, 2023   124,794      
Balance at beginning of period at Jun. 25, 2023 1,621.9 $ 0.2 3,711.0 (2,064.2) (25.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (689.3)        
Unrealized gain (loss) on available-for-sale securities 12.4        
Balance at end of period (in shares) at Mar. 31, 2024   125,833      
Balance at end of period at Mar. 31, 2024 1,022.6 $ 0.2 3,788.6 (2,753.5) (12.7)
Balance at beginning of period (in shares) at Sep. 24, 2023   125,321      
Balance at beginning of period at Sep. 24, 2023 1,245.7 $ 0.2 3,728.6 (2,459.9) (23.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (144.7)     (144.7)  
Unrealized gain (loss) on available-for-sale securities 11.0       11.0
Tax withholding on vested equity awards (2.0)   (2.0)    
Stock-based compensation (in shares)   104      
Stock-based compensation 29.8   29.8    
Exercise of stock options and issuance of shares under employee stock purchase plan (in shares)   360      
Exercise of stock options and issuance of shares under employee stock purchase plan 10.4   10.4    
Balance at end of period (in shares) at Dec. 31, 2023   125,785      
Balance at end of period at Dec. 31, 2023 1,150.2 $ 0.2 3,766.8 (2,604.6) (12.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (148.9)     (148.9)  
Unrealized gain (loss) on available-for-sale securities (0.5)       (0.5)
Tax withholding on vested equity awards (0.7)   (0.7)    
Stock-based compensation (in shares)   48      
Stock-based compensation 22.5   22.5    
Balance at end of period (in shares) at Mar. 31, 2024   125,833      
Balance at end of period at Mar. 31, 2024 $ 1,022.6 $ 0.2 3,788.6 (2,753.5) (12.7)
Balance at beginning of period (in shares) at Jun. 30, 2024 126,409 126,409      
Balance at beginning of period at Jun. 30, 2024 $ 882.1 $ 0.2 3,821.9 (2,928.4) (11.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (282.2)     (282.2)  
Unrealized gain (loss) on available-for-sale securities 7.3       7.3
Tax withholding on vested equity awards (3.6)   (3.6)    
Stock-based compensation (in shares)   479      
Stock-based compensation 25.3   25.3    
Balance at end of period (in shares) at Sep. 29, 2024   126,888      
Balance at end of period at Sep. 29, 2024 $ 628.9 $ 0.2 3,843.6 (3,210.6) (4.3)
Balance at beginning of period (in shares) at Jun. 30, 2024 126,409 126,409      
Balance at beginning of period at Jun. 30, 2024 $ 882.1 $ 0.2 3,821.9 (2,928.4) (11.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (939.9)        
Unrealized gain (loss) on available-for-sale securities $ 7.2        
Balance at end of period (in shares) at Mar. 30, 2025 155,623 155,623      
Balance at end of period at Mar. 30, 2025 $ 212.7 $ 0.2 4,085.2 (3,868.3) (4.4)
Balance at beginning of period (in shares) at Sep. 29, 2024   126,888      
Balance at beginning of period at Sep. 29, 2024 628.9 $ 0.2 3,843.6 (3,210.6) (4.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (372.2)     (372.2)  
Unrealized gain (loss) on available-for-sale securities (1.4)       (1.4)
Tax withholding on vested equity awards (0.1)   (0.1)    
Stock-based compensation (in shares)   99      
Stock-based compensation 19.7   19.7    
Issuance of shares under employee stock purchase plan (in shares)   773      
Issuance of shares under employee stock purchase plan 8.8   8.8    
Issuance of shares under the at-the-market offering program, net of issuance costs (in shares)   10,919      
Issuance of shares under the at-the-market offering program, net of issuance costs 88.9   88.9    
Balance at end of period (in shares) at Dec. 29, 2024   138,679      
Balance at end of period at Dec. 29, 2024 372.6 $ 0.2 3,960.9 (3,582.8) (5.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (285.5)     (285.5)  
Unrealized gain (loss) on available-for-sale securities 1.3       1.3
Tax withholding on vested equity awards (0.2)   (0.2)    
Stock-based compensation (in shares)   69      
Stock-based compensation 18.2   18.2    
Issuance of shares under the at-the-market offering program, net of issuance costs (in shares)   16,875      
Issuance of shares under the at-the-market offering program, net of issuance costs $ 106.3   106.3    
Balance at end of period (in shares) at Mar. 30, 2025 155,623 155,623      
Balance at end of period at Mar. 30, 2025 $ 212.7 $ 0.2 $ 4,085.2 $ (3,868.3) $ (4.4)